# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001185185-24-000650
Filing Date
2024-06-24
Accepted
2024-06-24 13:32:01
Documents
108
Period of Report
2024-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-K | igcpharma20240331_10k.htm iXBRL | 10-K | 1886363
2 | EXHIBIT 21.1 | ex_691484.htm | EX-21.1 | 40635
3 | EXHIBIT 23.1 | ex_691485.htm | EX-23.1 | 3208
4 | EXHIBIT 31.1 | ex_691486.htm | EX-31.1 | 15305
5 | EXHIBIT 31.2 | ex_691487.htm | EX-31.2 | 14760
6 | EXHIBIT 32.1 | ex_691488.htm | EX-32.1 | 8026
7 | EXHIBIT 32.2 | ex_691489.htm | EX-32.2 | 7397
8 | EXHIBIT 97 | ex_691490.htm | EX-97.1 | 14105
14 |  | igcpharma20240331_10kimg001.jpg | GRAPHIC | 1863
15 |  | igcpharma20240331_10kimg002.jpg | GRAPHIC | 10923
16 |  | igcpharma20240331_10kimg003.jpg | GRAPHIC | 12743
17 |  | igcpharma20240331_10kimg004.jpg | GRAPHIC | 10247
18 |  | igcpharma20240331_10kimg005.jpg | GRAPHIC | 16201
19 |  | igcpharma20240331_10kimg006.jpg | GRAPHIC | 15791
20 |  | igcpharma20240331_10kimg007.jpg | GRAPHIC | 12759
21 |  | igcpharma20240331_10kimg008.jpg | GRAPHIC | 17354
22 |  | igcpharma20240331_10kimg009.jpg | GRAPHIC | 29889
23 |  | igcpharma20240331_10kimg010.jpg | GRAPHIC | 7933
24 |  | igcpharma20240331_10kimg011.jpg | GRAPHIC | 15584
| Complete submission text file | 0001185185-24-000650.txt |  | 8778790

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL TAXONOMY EXTENSION SCHEMA | igc-20240331.xsd | EX-101.SCH | 63356
10 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | igc-20240331_cal.xml | EX-101.CAL | 50542
11 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | igc-20240331_def.xml | EX-101.DEF | 284853
12 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | igc-20240331_lab.xml | EX-101.LAB | 498606
13 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | igc-20240331_pre.xml | EX-101.PRE | 285968
111 | EXTRACTED XBRL INSTANCE DOCUMENT | igcpharma20240331_10k_htm.xml | XML | 1310418

Mailing Address 10224 FALLS ROAD POTOMAC MD 20854
Business Address 10224 FALLS ROAD POTOMAC MD 20854 301-983-0998
IGC Pharma, Inc. (Filer) CIK: 0001326205 (see all company filings)

EIN.: 202760393 | State of Incorp.: MD | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 001-32830 | Film No.: 241063515
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)